Stocks and Investing Stocks and Investing
Fri, June 26, 2020
Thu, June 25, 2020

Geoff Meacham Initiated (BBIO) at Hold and Held Target at $38 on, Jun 25th, 2020


Published on 2024-10-27 08:41:11 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of B of A Securities, Initiated "BridgeBio Pharma, Inc." (BBIO) at Hold and Held Target at $38 on, Jun 25th, 2020.

Geoff has made no other calls on BBIO in the last 4 months.



There are 3 other peers that have a rating on BBIO. Out of the 3 peers that are also analyzing BBIO, 0 agree with Geoff's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Geoff


  • Mani Foroohar of "SVB Leerink" Reiterated at Buy with Decreased Target to $39 on, Thursday, May 14th, 2020
  • Raghuram Selvaraju of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $50 on, Monday, April 13th, 2020
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $43 on, Tuesday, March 3rd, 2020
Contributing Sources